Drug of Abuse Testing Services Market Overview:

The global drug of abuse testing services market was valued at USD 2,735 million in 2021. It is projected to grow at a CAGR, of 5.8% between 2023 and 2032.

The market has experienced a significant increase in illicit and alcohol consumption. Market growth is also driven by government initiatives to combat and monitor substance abuse. Around 55% of substance abuse disorders are linked to opioids, and 25% to cannabis.

Global Drug of abuse Testing Services Market Analysis

Drug Type Analysis

With a 27.8% share, the cannabis/marijuana market dominated in 2021. This is due to marijuana, or cannabis, being the most widely used illicit drug in the entire world. The Substance Abuse & Mental Health Services Administration reported that marijuana was the most popular illicit drug in America in 2018. The market can be divided into marijuana/marijuana and alcohol. It also includes opioids and methamphetamines. LSD and other drugs are also available.

Request Covid - 19 Impact

In 2021, the opioids segment was second in terms of market share. This is due to the growing opioid crisis in key regions such as North America, Europe, and Asia. This includes heroin abuse and prescription pain relief. To expand their portfolio of opioids, market leaders are pursuing organic growth strategies.

End-User Analysis

End users report that the largest drug testing occurs in the workplace. Criminal justice is second. These segments together accounted for 69% of the global drug abuse testing market. Drug of abuse Professional OTC POC tests can help reduce the time it takes to diagnose and treat disease. The market share for home OTC drugs of addiction testing was the lowest.

Key Market Segments

By Product

• Alcohol
• Cocaine
• Cannabis/Marijuana
• Other Types

By End-User

• Lab-based
• Professional POC
• Home OTC
• Criminal Justice
• Employment Testing

Market Dynamics

Access to and availability of services is limited for people suffering from substance abuse disorders worldwide. Only 1 in 7 cases are treated annually. The U.S. has a favorable reimbursement system for treatment services, which has resulted in high demand for substance abuse treatments. The Centers for Medicare & Medicaid Services expanded their Medicare coverage to include Medication-assisted Treatment in opioid treatment programs, effective.

The market is driven by a variety of government initiatives to combat and monitor substance abuse. In 2020, the National Drug Control Budget requested USD 34.6 Billion to fund five areas of drug control in the U.S., namely prevention, operation, treatment, and law enforcement. The Substance Abuse and Mind Health Services Administration which funds the Substance Abuse Prevention and Treatment Block Grant to support evidence-based prevention activities, received approx. US$ 1.9 billion.

Every business is at risk from employees abusing drugs and alcohol. Employers conduct drug abuse testing programs to reduce these risks. However, this could be considered a violation in terms of privacy rights. Drug testing is subject to privacy laws in many countries. These tests can be performed using a variety of standards or criteria. Violations are considered violations of individual rights.

Regional Analysis

North America accounted for 40.6% of the global market share in 2021. This is largely due to the prominence of major players who are undertaking large expansion plans. The region's growing prevalence of substance abuse and the government's efforts to curb it can also explain its dominant position.

The increased prevalence of substance abuse disorder in the region due to the COVID-19 epidemic is expected to increase the demand for drug abuse testing services. The COVID-19 pandemic is expected to cause a decrease in demand for workplace drug testing services and slow market growth.

The rising demand from emerging countries for substance abuse testing services such as India and China is expected to drive Asia Pacific's growth. This segment is expected to expand due to the rising prevalence of substance abuse disorders in key Asia Pacific countries and ongoing efforts by regulators to manage them. The main barriers to market growth will be the lack of clear regulations on workplace drug testing and national lockdowns as a response to the COVID-19 pandemic.

Key Regions and Countries covered in thе rероrt:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Market Share & Key Players Analysis:

To capture large market shares, the key players employ different growth strategies such as product differentiation strategies and new product development. In 2019, Psyche medics Corporation signed a new distribution deal with Toxicologia Pardini Ltda. Sansao Holding S.A., Brazil. Toxicology Pardini and Sansao were named as distributors of Psyche medics hair drug testing services in Brazil. The company was able to expand its presence in the Brazilian market.

The following are some of the most prominent players in global drug abuse testing services:

Маrkеt Кеу Рlауеrѕ:

• Quest Diagnostics
• Abbott Laboratories
• Cordant Health Solutions
• Legacy Medical Services
• Omega Laboratories, Inc.
• Psychemedics Corporation
• Millennium Health
• Mayo Clinic Laboratories
• Precision Diagnostics
• LGC Group
• Other Key Players

For the Drug of Abuse Testing Services Market research study, the following years have been considered to estimate the market size: